AI assistant
Bliss GVS Pharma Limited — Share Issue/Capital Change 2020
Mar 7, 2020
61284_rns_2020-03-07_9d3d2baa-20a2-4903-ad37-aaddc140d5a1.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
~~bBLISS GVS PHARMA LTO.

March 07, 2020
| T o |
T o |
|---|---|
| he is ti T M L D tm t ng an ag er ep ar en , |
he al is ti T G M L D tm t ng en er an ag er ep ar en , |
| N io al S ck E h of In di at to n xc an ge a |
B S E L im it ed |
| l l G lo e lo ck P B t no , |
P hi Je ej bh T oy ro ze ee ow er s, |
| dr la C pl dr (E t) B K B an a- ur om ex an a as , , |
al al S D tr t, ee |
| M b ai 40 0 05 1 um - |
b ai M 40 00 0 1 um - |
| S b ol B L IS S G V S ym : |
S i C od 50 19 6 7 cr p e: |
Subject: Grant of Options under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
Dear Sirj Madam,
Pursuant to Regulation 30 of Securities and Exchange Board of India (SEBI)(Listing Obligations and Disclosure Requirements) Regulations, 2015 CListing Regulations') read with Para B of Part A of Schedule III of Listing Regulations and SEBICircular No. CIRjCFDjCMDj4j2015 dated September 09, 2015, we would like to inform you that the Members of Nomination and Remuneration Committee of the Board of Directors of the Company in its Meeting held today i.e. March 07, 2020 have approved grant of 27,61,000 Options out of 60,00,000 Options under Bliss GVS Pharma Limited- Employee Stock Options Plan 2019 to the eligible employees as per the details mentioned in Annexure A.
You are requested to take the aforementioned information on your records.
Thanking you.
Yours Faithfully, For Bliss GVS Pharma Limited
'-~"'"
S. N.Kamath Managing Director DIN: 00140593
End: ala
Factory : Regd. Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL. : (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: [email protected] • Website: www.blissgvs.com· CIN - L24230MH1984PLC034771 Plot No.1 0 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tal. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257 .• Ernail : [email protected]

ANNEXURE-A
| Sr N o. |
ti la P ar cu rs |
D ai ls et |
|---|---|---|
| 1 | B ri ef de il of O io G ed ta pt nt s ns ra |
27 ,6 1 ,0 00 (T Se L ak h Si O t xt y n s y w en ve ne |
| ho nd ti of ix T ) 60 ,0 0 ,0 00 (S t t s y u sa op on ou |
||
| ak h s) ti ha be d L in te te s op on ve en gr an rm s |
||
| of li ha im it ed pl B G V S P L E ss a - rm m oy ee |
||
| St k O io P la 20 19 b th N in io pt at n y e n oc ns om |
||
| d io C it R at te an em un er n om m e. |
||
| 2 | W he th th he is of SE B I in te e e s er sc m rm |
Y es |
| (if ul io 20 14 (S B E B ) R at eg ns , |
||
| pl ic ab le ) ap |
||
| 3 | al be of sh d T b ot nu m r ar es co ve re y |
th 60 ,0 0 ,0 00 it Sh N E ot e y m or an qu ar es |
| th ti e es op on s |
(E h k is ti bl in ti st to ac oc on co nv er e op |
|
| ui le be of sh of fa lu nt r eq va nu m ar es ce va e |
||
| of R 1/ ch ). e. - ea |
||
| 4 | P ri ci fo ul ng rm a |
E is P ri of R 43 /- ti / e s. r xe rc ce pe op on pe r |
| sh (B ed th SE C lo si N L t e e ng ar as up on as |
||
| M ke ic af de du in 65 di % t te ct nt e r ar pr g sc ou |
||
| d de in ed b th be of M te an as rm y e em rs in io d io |
||
| N R at at n om n an em un er C it e) te om m |
||
| 5 | O io ed pt st ns ve |
N il |
| 6 | T im it hi hi ch ti be e w n w on m |
T he ed ti sh al l be ci bl st ve on s ex er sa e |
| op ay ci d ex er se |
op it hi ri od of 4 (F r) fr th n a s ou ar om e w |
|
| pe ye da of in of ch ti te st g ve su op on s. |
||
| 7 | O io ci d pt ns ex er se |
il N |
| 8 | M al iz ed b ci of ti y se on ey re ex er op on s |
il N |
| 9 | he l be of sh is in T to ta r g as nu m ar es ar a |
il N |
| lt of ci of ti se on re su ex er op |
||
| 10 | O io la d pt ns p se |
il N |
| 1 1 |
V ia ti of of ti te s ar on rm op on s |
li bl N A ot pp ca e |
| 12 | ri ef de il of si if ic B ta t te s gn an rm s |
i ) he O io d ld in th T V pt te t to ns gr an ou es e w |
| li gi bl pl in (f in al lm E E 4 r) st ts e m oy ee ou en |
||
| in th fo ll in e g r ow m an ne :- |
||
| (a ) 25 of th l be of O io % to ta pt e r nu m ns |
||
| d af 12 th fr th te te r gr an m on s, om e |
||
| da of G of O io te nt pt ra ns |

$\bar{\mathbf{x}}$
| (b) 25% of the total number of Options granted after 24 months, from the date of Grant of Options. |
||
|---|---|---|
| (c) 25% of the total number of Options granted after 36 months, from the |
||
| date of Grant of Options. | ||
| (d) 25% of the total number of Options | ||
| granted after 48 months, from the | ||
| date of Grant of Options. ii) There shall be a minimum period of one |
||
| year between the grant of options and | ||
| vesting of options. | ||
| iii) The maximum exercise period for Exercise of an Option would be 6 (six) |
||
| months from the date of its Vesting. | ||
| iv) The Equity Shares arising out of Vested | ||
| Options under the scheme, shall be subject | ||
| to lock-in for a period of $6$ (six) months from the date of allotment of Equity Shares. |
||
| 13 | Subsequent changes or cancellation or | Not Applicable |
| exercise of such options | ||
| 14 | Diluted earnings per share pursuant to | Not Applicable. No options have been |
| issue of equity shares on exercise of options |
exercised yet. | |
$\sim$
$\bar{\mathbf{z}}$
$\alpha$
SISPHA $\leq$ . $\sqrt{6}$ $\frac{1}{2}$